JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugimachi, K
Right arrow Articles by Tsuneyoshi, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugimachi, K
Right arrow Articles by Tsuneyoshi, M
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Liver Cancer
Journal of Clinical Pathology 2003;56:854-860
© 2003 BMJ Publishing Group Ltd & Association of Clinical Pathologists


ORIGINAL ARTICLE

Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma

K Sugimachi1,2, S Tanaka2, K Taguchi1, S Aishima1, M Shimada2, M Tsuneyoshi1

1 Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
2 Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Correspondence to:
Dr S Tanaka
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University. 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; shinjit{at}surg2.med.kyushu-u.ac.jp Aim: Angiopoietin 1 (Ang-1) and its antagonist, angiopoietin 2 (Ang-2), are novel ligands that regulate the Tie2 receptor. The Ang-2 gene is upregulated in the hypervascular type of human hepatocellular carcinoma (HCC). To gain a better understanding of the role of the Ang–Tie2 system in HCC the expression of these genes was investigated in a series of human HCCs.

Methods: The expression of the angiopoietin and Tie2 proteins was investigated in nine normal liver tissues and 52 surgically resected HCCs. In addition, the effects of hypoxic stimuli on Ang-1, Ang-2, vascular endothelial growth factor (VEGF), and erythropoietin (EPO) expression was investigated in Hep3B cells.

Results: Ang-1, rather than Ang-2, was more frequently expressed in the normal liver. Ang-1 was expressed in 68% of HCCs, whereas Ang-2 was expressed in 81%, and was significantly higher in poorly differentiated HCCs characterised by high vascularity (p = 0.02), and in tumours with a peliotic change (p = 0.02). Strong expression of Tie2 was seen in tumour vessels in accordance with Ang-2 expression. In Hep3B cells, hypoxic stimuli upregulated VEGF and EPO, but not Ang-1 or Ang-2.

Conclusions: These data support the evidence that the reversal of Ang-1 and Ang-2 expression plays an important role in the angiogenic and dedifferentiation processes in HCC. The hypoxic stimuli were not responsible for Ang-2 upregulation, unlike that of VEGF, in human HCC cells.


Keywords: angiopoietin; Tie2; hypoxia; angiogenesis; hepatocellular carcinoma

Abbreviations: Ang, angiopoietin; EC, vascular endothelial cell; EPO, erythropoietin; HCC, hepatocellular carcinoma; HIF, hypoxia inducible factor; PC, vascular pericyte/smooth muscle cell; PCR, polymerase chain reaction; RT, reverse transcriptase; Tie2, tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 2; VEGF, vascular endothelial growth factor




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
M. Scharpfenecker, U. Fiedler, Y. Reiss, and H. G. Augustin
The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism
J. Cell Sci., February 15, 2005; 118(4): 771 - 780.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.